GL1X · GenesisL1 explorer

MolNFT v1 · #144058 · protein

Trastuzumab Fab D185A (light chain) mutant.

6BHZ · Trastuzumab anti-HER2 Fab heavy chain: “Trastuzumab Fab D185A (light chain) mutant.”. X-ray diffraction, 10 pockets (best druggability 0.67). MolNFT v1 #144058 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6BHZ
Type
protein
Length
845 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Trastuzumab anti-HER2 Fab heavy chain; Trastuzumab anti-HER2 Fab light chain D185A
Pockets
10 · best druggability 0.67

Structure

x-ray diffraction · 4 distinct chains · 8% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HTrastuzumab anti-HER2 Fab heavy chainprotein21210% helix, 51% strand—
LTrastuzumab anti-HER2 Fab light chain D185Aprotein2136% helix, 52% strand—
ITrastuzumab anti-HER2 Fab heavy chainprotein2069% helix, 53% strand—
MTrastuzumab anti-HER2 Fab light chain D185Aprotein2146% helix, 50% strand—

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 4 copies · chains L, I, M

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17510.670.7575empty
23940.570.7548empty
33070.540.7537empty
4920.330.7320empty
5790.330.7418empty

Interfaces

3 interfaces between chains.

  • H–L · 1720 Ų buried · 14 hydrogen bonds · protein-protein
  • I–M · 1601 Ų buried · 13 hydrogen bonds · protein-protein
  • H–I · 686 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6BHZ · Trastuzumab Fab D185A (Light Chain) Mutant. · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.